No photo of Ismael Qasim Husein Barzinji
20192023

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.
  • 1 Similar Profiles

Collaborations from the last five years

Dive into details by clicking on the dots.
  • Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

    Roos, I., Hughes, S., McDonnell, G., Malpas, C. B., Sharmin, S., Boz, C., Alroughani, R., Ozakbas, S., Buzzard, K., Skibina, O., van der Walt, A., Butzkueven, H., Lechner-Scott, J., Kuhle, J., Terzi, M., Laureys, G., Van Hijfte, L., John, N., Grammond, P., Grand'Maison, F., & 17 othersSoysal, A., Jensen, A. V., Rasmussen, P. V., Svendsen, K. B., Barzinji, I., Nielsen, H. H., Sejbæk, T., Prakash, S., Stilund, M. L. M., Weglewski, A., Issa, N. M., Kant, M., Sellebjerg, F., Gray, O., Magyari, M., Kalincik, T. & MSBase Study GroupDanish MS Registry Study Group, 14 Aug 2023, In: JAMA Neurology. 80, 8, p. 789-797 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

    7 Citations (Scopus)
  • Neurosarkoidose

    Translated title of the contribution: NeurosarcoidosisChristensen, P. B., Yavarian, Y., Holm, I., Barzinji, I. & Kristensen, C. C. H., 5 Sept 2022, In: Ugeskrift for laeger. 184, 17, p. 1604-1607 4 p., V09210704.

    Research output: Contribution to journalJournal articleResearchpeer-review

    Open Access
    File
    5 Downloads (Pure)
  • Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study

    Buron, M. D., Chalmer, T. A., Sellebjerg, F., Barzinji, I., Christensen, J. R., Christensen, M. K., Hansen, V., Illes, Z., Jensen, H. B., Kant, M., Papp, V., Petersen, T., Rasmussen, P. V., Schäfer, J., Theódórsdóttir, Á., Weglewski, A., Sorensen, P. S. & Magyari, M., 25 Aug 2020, In: Neurology. 95, 8, p. e1041-e1051

    Research output: Contribution to journalJournal articleResearchpeer-review

    73 Citations (Scopus)
  • Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis: a nationwide cohort study

    Buron, M. D., Chalmer, T. A., Barzinji, I., Christensen, J. R., Christensen, M. K. B., Hansen, V., Illes, Z., Jensen, H. B., Kant, M., Petersen, T., Rasmussen, P. V., Schafer, J., Sellebjerg, F., Theodorsdottir, A., Weglewski, A., Sorensen, P. S. & Magyari, M., 2019, In: Multiple Sclerosis Journal. 25, Suppl. 2, p. 512-513 2 p., P975.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

    6 Citations (Scopus)